Drug-drug interactions and risk of bleeding among inpatients on warfarin therapy: a prospective observational study - Test2 - elhamkhani - TriplyDB

Drug-drug interactions and risk of bleeding among inpatients on warfarin therapy: a prospective observational study

Drug-drug interactions and risk of bleeding among inpatients on warfarin therapy: a prospective observational study

http://www.wikidata.org/entity/Q34228198

about

Should lifelong anticoagulation for unprovoked venous thromboembolism be revisited?Profile and anticoagulation outcomes of patients on warfarin therapy in an urban hospital in Cape Town, South Africa.Is dabigatran efficacy enough to prevent stroke in atrial fibrillation patient with high CHADS2 score during peri-procedural catheter radiofrequency ablation? A case report with literature review.Cytochrome P450 interactions are common and consequential in Massachusetts hospital discharges.Nystatin and miconazole: pharmacological and clinical evidence regarding interactions with warfarin.Study of warfarin utilization in hospitalized patients: analysis of possible drug interactions.Characteristics of patients with thromboembolic disorders on warfarin therapy in resource limited settings

P2860

Q36201247-4C708625-69B5-49A4-9886-EE659F8AEBA0 Q37019758-03EB2F23-1114-48AA-984A-9AAEAF768428 Q38541307-5E42C7DF-4CF3-46A0-9D92-C3B4F49AF78F Q38684358-5455DD5B-D1A5-4737-B45B-DE6F3502F0D2 Q39601797-0BAF9AA3-9D8A-4315-BFBD-3026139BE829 Q40672590-FCE425A6-CACA-4FFD-ABA6-8604385A8DD6 Q58720888-C255B563-E925-479A-B141-B87C677C7038

P2860

Drug-drug interactions and risk of bleeding among inpatients on warfarin therapy: a prospective observational study

http://www.wikidata.org/entity/Q34228198

description

2014 nî lūn-bûn

@nan

2014 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի սեպտեմբերին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Drug-drug interactions and ris ...... rospective observational study

@ast

Drug-drug interactions and ris ...... rospective observational study

@en

Drug-drug interactions and ris ...... rospective observational study

@nl

type

label

Drug-drug interactions and ris ...... rospective observational study

@ast

Drug-drug interactions and ris ...... rospective observational study

@en

Drug-drug interactions and ris ...... rospective observational study

@nl

prefLabel

Drug-drug interactions and ris ...... rospective observational study

@ast

Drug-drug interactions and ris ...... rospective observational study

@en

Drug-drug interactions and ris ...... rospective observational study

@nl

P1433

Q34228198-22ABD18F-2394-448F-B4ED-349D9A15FDAD

P1476

Q34228198-D8E7342E-B9BF-4131-B041-39F8491B2B49

P2093

Q34228198-181B8E5C-6AF2-4589-9CC2-ECE5D1CCE960

Q34228198-BE362E1B-B443-4192-8DED-401D72BAAD20

Q34228198-C7FDAE0A-9B95-493D-BA09-2F28AFA67EC2

Q34228198-D7069397-B3D6-4FE9-B330-2CC368AFD6DD

P2860

Q34228198-03370236-1911-4DAE-A520-FE94A0D618A1

Q34228198-0378F9DA-9AFD-402F-8DED-5D244195EB68

Q34228198-0ACAFF51-6E45-4C14-96B0-8F107B34A90B

Q34228198-15382392-86A6-4B3C-8F73-2B0CEC927C97

Q34228198-1748746C-3315-44C5-9CBE-637DCB05D651

Q34228198-19021B3E-D682-4551-8EA4-941F87ADCAEF

Q34228198-25918E04-D9D9-4202-9142-1ED2273A0648

Q34228198-2F6DC000-C65F-4918-8FB6-C1583CB0CE1F

Q34228198-324B84FC-58CA-4FB2-94E0-C9BBE38F0975

Q34228198-330043EE-69AD-4150-8030-2F3BB34BD5A5

P2888

Q34228198-BDB8E187-E4DE-4D88-B132-987B94A8C3B1

P304

Q34228198-64544EE5-A902-4BB4-AC1F-E520E848C7D9

P31

Q34228198-BD851756-90E6-4E83-8C03-46791E742D46

P356

Q34228198-0A5AFDF0-1B17-46D0-9FAC-B225E17AE0E0

P478

Q34228198-639192D2-9E2E-4A04-82E9-D1490B4D14C7

P577

Q34228198-4319E97F-5F06-4CE9-9392-C1CF19C7E151

P5875

Q34228198-C23CDB7D-7788-47AC-9229-8B19CEFE1666

P6179

Q34228198-9271F6E7-2FE1-4B41-A3FE-8F9989081C2B

P698

Q34228198-25E5EE55-85D4-4C78-8EA2-A69E411E48B8

P932

Q34228198-AC8AE526-0F17-48F2-8FE9-7049116709E6

P356

1477-9560-12-20

P1433

Thrombosis journal

P1476

Drug-drug interactions and ris ...... rospective observational study

@en

P2093

Befikadu Legesse

http://www.w3.org/2001/XMLSchema#string

Gebrehiwot Teklay

http://www.w3.org/2001/XMLSchema#string

Mebratu Legesse Bekele

http://www.w3.org/2001/XMLSchema#string

Nuredin Shiferaw

http://www.w3.org/2001/XMLSchema#string

P2860

Drug interactions and risk of acute bleeding leading to hospitalisation or death in patients with chronic atrial fibrillation treated with warfarin

Utilization review of concomitant use of potentially interacting drugs in Thai patients using warfarin therapy

Quality of anticoagulation and use of warfarin-interacting medications in long-term care: a chart review.

Characteristics of ambulatory anticoagulant adverse drug events: a descriptive study

Warfarin-associated bleeding events and concomitant use of potentially interacting medicines reported to the Norwegian spontaneous reporting system

Assessment of drug use pattern using WHO prescribing indicators at Hawassa University Teaching and Referral Hospital, south Ethiopia: a cross-sectional study.

The risk of overanticoagulation with antibiotic use in outpatients on stable warfarin regimens.

Warfarin toxicity and individual variability-clinical case.

Risk factors for bleeding in patients taking coumarins.

Pharmacogenetics of warfarin: current status and future challenges.

P2888

1477-9560-12-20

P304

20

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/1477-9560-12-20

http://www.w3.org/2001/XMLSchema#string

P478

12

http://www.w3.org/2001/XMLSchema#string

P577

2014-09-17T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

266386977

http://www.w3.org/2001/XMLSchema#string

P6179

1001165565

http://www.w3.org/2001/XMLSchema#string

P698

25249791

http://www.w3.org/2001/XMLSchema#string

P932

4171718

http://www.w3.org/2001/XMLSchema#string